The deal builds on leadership positions in Allergan's core therapeutic areas.
The portfolio still loves the stock, but now is the time to take profits.
ValueAct Capital has a history of investing at the right time of a down cycle.
Support has appeared around $95 recently, but that may give way.
This small-cap is trading below net cash and is rapidly improving its fundamentals.
Do earnings and lower guidance no longer matter to investors?
Metals and minerals had the highest operating margin in a decade.
Is the electric-car maker a money pit -- or the next big thing?
The shocking truth of how the latest round of stimulus under Abenomics is being spent.
Consider using a 'ratio/calendar spread' ahead of earnings reports like Zendesk's.

Columnist Conversations

This morning United Technologies reported GAAP eps of $1.74 up 8% from a year ago. In Q3, sales were up by 5% ...
Today's headlines include a number of bad reports and poor stock market reactions in some major restaurant com...
Market opens slightly flat to begin trading Tuesday.  Oil slightly down and the dollar is stronger in ear...
General Motors is moving well today.  The stock is up just over 2.5% with the help of  nice bump in ...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.